A company has applied to the FSA for Galacto-oligosaccharide (GOS) to be approved for use in the European Union under the simplified approval procedure.
They are requesting an opinion from the FSA on the equivalence of their product to a competitior product that was already marketed in the EU prior to 15 May 1997. The European Novel Foods Regulation includes a simplified approval procedure for when a company believes its novel food is substantially equivalent to a food that is already on the market. In such a situation, the applicant can submit a notification to the European Commission after obtaining an opinion on equivalence from an EU member state – in this case the UK.
The FSA will present the company’s application dossier to the independent expert committee and views are wanted on the dossier.
The closing date for submissions is 9 November 2017.